For: | Duarte-Rojo A, Ruiz-Margáin A, Macias-Rodriguez RU, Cubero FJ, Estradas-Trujillo J, Muñoz-Fuentes RM, Torre A. Clinical scenarios for the use of S100β as a marker of hepatic encephalopathy. World J Gastroenterol 2016; 22(17): 4397-4402 [PMID: 27158209 DOI: 10.3748/wjg.v22.i17.4397] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v22/i17/4397.htm |
Number | Citing Articles |
1 |
Bae-Hwan Kim, Se-Hoon Jung, Suryun Jung. Beet root (Beta vulgaris) protects lipopolysaccharide and alcohol-induced liver damage in rat. Toxicological Research 2020; 36(3): 275 doi: 10.1007/s43188-019-00030-4
|
2 |
Tarana Gupta, Sahaj Rathi, Radha K Dhiman. Managing Encephalopathy in the Outpatient Setting. Euroasian Journal of Hepato-Gastroenterology 2017; 7(1): 48 doi: 10.5005/jp-journals-10018-1211
|
3 |
Bora Dinc, Ilker Onguc Aycan, Mutay Aslan, Necmiye Hadimioglu, Zeki Ertug, Abdullah Kisaoglu, Ismail Demiryilmaz. Evaluation of Preoperative and Postoperative S100β and NSE Levels in Liver Transplantation and Right Lobe Living-Donor Hepatectomy: A Prospective Cohort Study. Transplantation Proceedings 2021; 53(1): 16 doi: 10.1016/j.transproceed.2020.04.1818
|
4 |
Yan Wang, Yu-Feng Xue, Yi-Fan Xu, Ming-Wei Wang, Jing Guan, Xi Chen. Elevated serum neurofilament light chain levels are associated with hepatic encephalopathy in patients with cirrhosis. Metabolic Brain Disease 2024; 39(6): 1099 doi: 10.1007/s11011-024-01381-0
|
5 |
Sahaj Rathi, Radha K. Dhiman. Managing encephalopathy in the outpatient setting. Clinical Liver Disease 2016; 8(6): 150 doi: 10.1002/cld.590
|
6 |
Shanling Mu, Hong Ma, Jun Shi, Dezhi Zhen. The expression of S100B protein in serum of patients with brain metastases from small-cell lung cancer and its clinical significance. Oncology Letters 2017; doi: 10.3892/ol.2017.7089
|
7 |
Anna Czarnecka, Marta Obara-Michlewska, Dorota Wesół-Kucharska, Milena Greczan, Magdalena Kaczor, Janusz Książyk, Dariusz Rokicki, Magdalena Zielińska. S100B Protein but Not 3-Nitrotyrosine Positively Correlates with Plasma Ammonia in Patients with Inherited Hyperammonemias: A New Promising Diagnostic Tool?. Journal of Clinical Medicine 2023; 12(6): 2411 doi: 10.3390/jcm12062411
|
8 |
Radha K. Dhiman, Sahaj Rathi. Evidence‐based Gastroenterology and Hepatology 4e. 2019; : 676 doi: 10.1002/9781119211419.ch44
|
9 |
Hendrik Strebel, Bernhard Haller, Maximilian Sohn, Wolfgang Schepp, Felix Gundling. Role of Brain Biomarkers S-100-Beta and Neuron-Specific Enolase for Detection and Follow-Up of Hepatic Encephalopathy in Cirrhosis before, during and after Treatment with L-Ornithine-L-Aspartate. GE - Portuguese Journal of Gastroenterology 2020; 27(6): 391 doi: 10.1159/000507225
|
10 |
Mariana Verdelho Machado. Liquid Diagnosis of Hepatic Encephalopathy: Are We There Already?. GE - Portuguese Journal of Gastroenterology 2020; 27(6): 378 doi: 10.1159/000510059
|
11 |
Carlos Pérez-Monter, Aldo Torre-Delgadillo. Astrocyte - Physiology and Pathology. 2018; doi: 10.5772/intechopen.72506
|
12 |
Wojciech Pisarek. S100 Beta Protein as a Marker of Hepatic Encephalopathy: A Breakthrough in Diagnostics or a False Trail? Review of the Literature.. Postępy Higieny i Medycyny Doświadczalnej 2022; 76(1): 128 doi: 10.2478/ahem-2022-0018
|